Fuji France selects Barco's mammo LCD display

TriMed Staff | | Health Imaging | Practice Management
Fuji Médical Systèmes, the French division of FujiFilm Medical Systems, has placed its first order for Barco's new Coronis 5 mega-pixel (MP) Mammo, a dedicated flat panel display system for digital mammography.

The order came immediately after the official product was launched in May. The agreement extends the pair's existing partnership. Fuji France has been integrating Barco's CRT-based MeDis 5MP and MammoMeDis HD display systems into their dedicated applications for digital mammography for several years.

Barco's system bundles two 5MP, 21.3-inch grayscale flat-panel displays with built-in I-Gaurd sensors, an ultra-fast, dual-head BarcoMed display controller, MediCal Pro softcopy QA software, a display driver and digital cabling.

TriMed Staff

Related Content

Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups
Not all lead glasses are created equal

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.